Clinical trials
Completed Endocrine System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
184 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 7 |
| 2013 | 10 |
| 2014 | 16 |
| 2015 | 8 |
| 2016 | 7 |
| 2017 | 9 |
| 2018 | 15 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 14 |
| 2022 | 4 |
| 2023 | 9 |
| 2024 | 3 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 184 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Center for Research Resources (NCRR) | 20 |
| AstraZeneca | 7 |
| Eli Lilly and Company | 7 |
| Merck Sharp & Dohme LLC | 5 |
| University Hospital, Basel, Switzerland | 5 |
| University of Pittsburgh | 5 |
| Ascendis Pharma Endocrinology Division A/S | 4 |
| University of Cambridge | 4 |
| Ascendis Pharma A/S | 2 |
| Catalysis SL | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 184 |
| Diabetes Mellitus | 61 |
| Glucose Metabolism Disorders | 61 |
| Metabolic Diseases | 61 |
| Diabetes Mellitus, Type 2 | 42 |
| Rare Diseases | 28 |
| Autoimmune Diseases | 20 |
| Diabetes Mellitus, Type 1 | 19 |
| Insulin Resistance | 13 |
| Immune System Diseases | 12 |
Trials
Showing 51 to 75 of 184. Each trial links to its page on Pharma Observatory.
84 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.